FMP
Harmony Biosciences Holdings, Inc.
HRMY
NASDAQ
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
29.32 USD
0.39 (1.33%)
About
ceo
Dr. Jeffrey M. Dayno M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.harmonybiosciences.com
exchange
NASDAQ
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
CIK
0001802665
ISIN
US4131971040
CUSIP
413197104
Address
630 West Germantown Pike
Phone
484 539 9800
Country
US
Employee
246
IPO Date
Aug 19, 2020
Summary
CIK
0001802665
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
413197104
ISIN
US4131971040
Country
US
Price
29.32
Beta
0.72
Volume Avg.
373.19k
Market Cap
1.66B
Shares
-
52-Week
18.611-39.265
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
13.77
P/B
-
Website
https://www.harmonybiosciences.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HRMY News
It looks like there's no news available.
